Biologically active filtration (BAF) for metabolic 1,4-dioxane removal from contaminated groundwater.

J Hazard Mater

Department of Civil Engineering, Stony Brook University, Stony Brook, NY 11794, United States; New York State Center for Clean Water Technology, Stony Brook University, Stony Brook, NY 11794, United States. Electronic address:

Published: March 2025

1,4-Dioxane is a persistent contaminant that is not effectively removed by conventional water treatment processes. In this study, bench-scale granular activated carbon (GAC)-based biologically active filtration (BAF) systems were developed to metabolically degrade 1,4-dioxane at environmentally relevant levels (<1000 μg L). BAF was established using predeveloped biologically activated carbon particles by mixing a 1,4-dioxane-degrading microbial community with granular activated carbon. 1,4-Dioxane removal performance was examined at a range of 1,4-dioxane concentrations (100-1000 μg L), hydraulic loading rates (3.6-14 cm h), and with the presence of co-contaminants (natural organic matter (NOM) and 1,1-DCE). BAFs achieved 69 ± 7 % removal with an influent 1,4-dioxane concentration of 100 μg L and hydraulic loading rates of 3.6-14 cm h, with the lowest effluent concentration of 21 μg L. The presence of NOM and 1,1-DCE negatively and irreversibly impacted 1,4-dioxane removal performance of BAF, and pretreatment processes to remove co-contaminants are crucial to maintain the 1,4-dioxane removal efficiency. Microbial analysis revealed the enrichment of 1,4-dioxane degrading species (CB1190-like bacteria) and functional genes responsible for 1,4-dioxane biodegradation (dxmB and aldh) at the top 12 cm of the columns, suggesting the effectiveness of biological 1,4-dioxane removal within short column lengths. This study demonstrated effective metabolic 1,4-dioxane removal at environmentally relevant concentrations by the BAFs, and can provide insights into designing better 1,4-dioxane remediation strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhazmat.2025.137827DOI Listing

Publication Analysis

Top Keywords

biologically active
8
active filtration
8
filtration baf
8
baf metabolic
4
metabolic 14-dioxane
4
14-dioxane removal
4
removal contaminated
4
contaminated groundwater
4
groundwater 14-dioxane
4
14-dioxane persistent
4

Similar Publications

OMEGA-guided DNA polymerases enable random mutagenesis in a tunable window.

Trends Biotechnol

March 2025

Tidetron Bioworks Technology (Guangzhou) Co., Ltd, Guangzhou Qianxiang Bioworks Co., Ltd, Guangzhou, Guangdong 510000, PR China. Electronic address:

Targeted random mutagenesis is crucial for breeding, directed evolution, and gene function studies, yet efficient tools remain scarce. Here, we present obligate mobile element guided activity (OMEGA)-R, an innovative targeted random mutagenesis system that integrates SpyCatcher-enIscB and PolI3M-TBD-SpyTag, outperforming existing state-of-the-art technologies in key metrics, such as protein size, mutagenesis efficiency, window length, and continuity. OMEGA-R achieves a dramatic enhancement of on-target mutagenesis, reaching a rate of 1.

View Article and Find Full Text PDF

Introduction: As of 24 October 2021, 128,868 laboratory-confirmed COVID-19 cases and 3550 deaths were reported from Namibia. The national COVID-19 vaccination campaign that started in March 2021 included health workers (HWs) as a priority group. The vaccines most administered were Sinopharm, AstraZeneca, Pfizer-BioNtech, and Janssen.

View Article and Find Full Text PDF

CARs for lymphoma.

Best Pract Res Clin Haematol

December 2024

Department of Medicine, Division of Hematology and Hematologic Malignancies, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Chimeric Antigen Receptor (CAR)-T cell therapy has revolutionized treatment options for B-cell Non-Hodgkin Lymphoma (NHL). CD19-targeting CAR-T cell therapy is approved for treatment in Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. CAR-T cells demonstrate robust and durable responses even in heavily pretreated patients.

View Article and Find Full Text PDF

In situ global mapping of protein perturbations via protein abundance and conformation analysis.

Anal Chim Acta

May 2025

State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 639 Longmian Dadao, Nanjing, 211198, China. Electronic address:

Background: Traditional studies of protein responses to external stimuli primarily focus on changes in protein abundance, often overlooking the critical role of protein conformational alterations. To address this gap, we developed Protein Abundance and Conformation Analysis (PACA), an integrative method that quantifies both protein abundance and conformational changes. PACA combines conventional quantitative proteomics for abundance measurements with Target Response Accessibility Profiling (TRAP), a technique that captures conformational changes in situ by applying reductive dimethylation to label accessible lysine residues in living cells before lysis.

View Article and Find Full Text PDF

Due to bleomycin's cytotoxic characteristics, which include cardiotoxicity, this investigation looked at the effectiveness of costus ethanolic extract in reducing cardiotoxicity in male rats receiving bleomycin therapy. Forty adult male rats (160-200 g) were evenly allocated into four groups: group (1) included normal rats serving as the control; group (2) included normal rats administered 200 mg/kg of costus ethanolic extract (CEE) orally for 6 weeks; group (3) consisted of rats receiving bleomycin (15 mg/kg twice weekly, ip) for 6 weeks; and group (4) involved rats treated orally with CEE (200 mg/kg/day) for 6 weeks following bleomycin intoxication. The results indicated that the CEE significantly reversed the cardiological deteriorations brought on by bleomycin; this was demonstrated by a considerable increase in cardiac SOD, GPx, GSH, and CAT, along with a substantial decrease in cardiac MDA, NO, and DNA fragmentation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!